Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC421

Vútrisíran

  • Status:
    Veitt
  • Application date:
    6.2.2023
  • Application published:
    15.3.2023
  • Grant published:
    15.10.2024
  • Max expiry date:
    27.7.2036
  • Medicine name:
    Amvuttra
  • Medicine for children:
    No

Timeline

Today
6.2.2023Application
15.3.2023Publication
15.10.2024Registration
27.7.2036Expires

Marketing license

  • IS authorization number:
    EU/1/22/1683
  • Date:
    10.10.2022
  • Foreign authorization number:
    EU/1/22/1681
  • Date:
    15.9.2022

Owner

  • Name:
    Alnylam Pharmaceuticals, Inc.
  • Address:
    300 Third Street, 3rd Floor, Cambridge, MA 02142 US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 16.09.2024

Upload documents